| Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19) C Agrati, A Sacchi, V Bordoni, E Cimini, S Notari, G Grassi, R Casetti, ... Cell Death & Differentiation 27 (11), 3196-3207, 2020 | 245 | 2020 |
| Humoral-and T-cell–specific immune responses to SARS-CoV-2 mRNA vaccination in patients with MS using different disease-modifying therapies C Tortorella, A Aiello, C Gasperini, C Agrati, C Castilletti, S Ruggieri, ... Neurology 98 (5), e541-e554, 2022 | 166 | 2022 |
| An inflammatory profile correlates with decreased frequency of cytotoxic cells in coronavirus disease 2019 V Bordoni, A Sacchi, E Cimini, S Notari, G Grassi, E Tartaglia, R Casetti, ... Clinical Infectious Diseases 71 (16), 2272-2275, 2020 | 120 | 2020 |
| Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome A Sacchi, G Grassi, V Bordoni, P Lorenzini, E Cimini, R Casetti, ... Cell death & disease 11 (10), 921, 2020 | 115 | 2020 |
| Humoral and cellular immune response elicited by mRNA vaccination against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in people living with human … A Antinori, S Cicalini, S Meschi, V Bordoni, P Lorenzini, A Vergori, ... Clinical Infectious Diseases 75 (1), e552-e563, 2022 | 95 | 2022 |
| Expansion of myeloid derived suppressor cells contributes to platelet activation by L-arginine deprivation during SARS-CoV-2 infection A Sacchi, G Grassi, S Notari, S Gili, V Bordoni, E Tartaglia, R Casetti, ... Cells 10 (8), 2111, 2021 | 47 | 2021 |
| The unbalanced p53/SIRT1 axis may impact lymphocyte homeostasis in COVID-19 patients V Bordoni, E Tartaglia, A Sacchi, GM Fimia, E Cimini, R Casetti, S Notari, ... International Journal of Infectious Diseases 105, 49-53, 2021 | 47 | 2021 |
| Coordinated cellular and humoral immune responses after two‐dose SARS‐CoV2 mRNA vaccination in liver transplant recipients G D’Offizi, C Agrati, U Visco‐Comandini, C Castilletti, V Puro, P Piccolo, ... Liver International 42 (1), 180-186, 2022 | 40 | 2022 |
| The role of P-selectin in COVID-19 coagulopathy: an updated review C Agrati, A Sacchi, E Tartaglia, A Vergori, R Gagliardini, A Scarabello, ... International journal of molecular sciences 22 (15), 7942, 2021 | 38 | 2021 |
| Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response C Montaldo, M Terri, V Riccioni, C Battistelli, V Bordoni, G D’Offizi, ... Journal of Hepatology 75 (6), 1301-1311, 2021 | 37 | 2021 |
| Impact of ART on dynamics of growth factors and cytokines in primary HIV infection V Bordoni, A Sacchi, R Casetti, E Cimini, E Tartaglia, C Pinnetti, A Mondi, ... Cytokine 125, 154839, 2020 | 25 | 2020 |
| Strong immunogenicity of heterologous prime-boost immunizations with the experimental vaccine GRAd-COV2 and BNT162b2 or ChAdOx1-nCOV19 C Agrati, S Capone, C Castilletti, E Cimini, G Matusali, S Meschi, ... npj Vaccines 6 (1), 131, 2021 | 23 | 2021 |
| Myeloid-derived suppressor cells in COVID-19: the paradox of good G Grassi, S Notari, S Gili, V Bordoni, R Casetti, E Cimini, E Tartaglia, ... Frontiers in immunology 13, 842949, 2022 | 21 | 2022 |
| Immunogenicity and reactogenicity of modified vaccinia Ankara pre-exposure vaccination against mpox according to previous smallpox vaccine exposure and HIV infection … V Mazzotta, AC Lepri, G Matusali, E Cimini, P Piselli, C Aguglia, S Lanini, ... EClinicalMedicine 68, 2024 | 20 | 2024 |
| Impact of prior influenza and pneumoccocal vaccines on humoral and cellular response to SARS-CoV-2 BNT162b2 vaccination V Puro, C Castilletti, C Agrati, D Goletti, S Leone, A Agresta, E Cimini, ... Vaccines 9 (6), 615, 2021 | 20 | 2021 |
| Mpox as AIDS-defining event with a severe and protracted course: clinical, immunological, and virological implications C Pinnetti, E Cimini, V Mazzotta, G Matusali, A Vergori, A Mondi, M Rueca, ... The Lancet Infectious Diseases 24 (2), e127-e135, 2024 | 19 | 2024 |
| Neutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters M Rescigno, C Agrati, C Salvarani, D Giannarelli, M Costantini, ... Frontiers in Immunology 14, 1104124, 2023 | 19 | 2023 |
| Evaluation of cross-immunity to the mpox virus due to historic smallpox vaccination G Matusali, E Petruccioli, E Cimini, F Colavita, A Bettini, E Tartaglia, ... Vaccines 11 (10), 1541, 2023 | 16 | 2023 |
| Premature aging of the immune system affects the response to SARS-CoV-2 mRNA vaccine in β-thalassemia: role of an additional dose R Carsetti, C Agrati, VM Pinto, B Gianesin, R Gamberini, M Fortini, ... Blood, The Journal of the American Society of Hematology 140 (15), 1735-1738, 2022 | 12 | 2022 |
| Neutralizing activity and T-cell response after bivalent fifth dose of messenger RNA vaccine in people living with HIV A Vergori, G Matusali, AC Lepri, E Cimini, M Fusto, F Colavita, ... International Journal of Infectious Diseases 134, 195-199, 2023 | 10 | 2023 |
